Prognostic Value of Plasma HER2 Gene Copy Number in HER2-Positive Metastatic Breast Cancer Treated with First-Line Trastuzumab

Ran, R; Huang, WF; Liu, YX; Shao, L; Liu, XR; Niu, YY; Kong, WY; Bo, SP; Rugo, HS; Lu, SJ; Li, HP

Li, HP (corresponding author), Peking Univ, Dept Breast Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing,Canc Hosp & Inst, Beijing 100142, Peoples R China.; Rugo, HS (corresponding author), Univ Calif San Francisco, Helen Diller Family Comp, San Francisco, CA 94143 USA.

ONCOTARGETS AND THERAPY, 2020; 13 (): 4385

Abstract

Objective: Patients with HER2-positive metastatic breast cancer (MBC) benefit from trastuzumab-based therapy but eventually develop intrinsic or acqui......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索